NEW YORK – March 26, 2026 – CMA, a leading provider of investment banking and turnaround & restructuring advisory services to the middle market, today announced that it has been named recipient of the Divestiture of the Year award at the 20th Annual Turnaround Awards, hosted by the M&A Advisor during the 2026 Distressed Investing Summit in Palm Beach, Florida.
The M&A Advisor recognized CMA’s Strategic & Transaction Advisory team for its exceptional work guiding HealthTronics, a premier provider of kidney stone management solutions for urologists, health systems, and patients, through a successful recapitalization and new investment from Secretariat Capital.
“It’s an honor to be recognized by the M&A Advisor at the 20th Annual Turnaround Awards, and a privilege to work with HealthTronics on a number of initiatives that will continue to unlock value and support its long-term success,” said Ben Godbout, Head of Strategic & Transaction Advisory.
“This milestone represents an exciting step forward for the HealthTronics team and reflects the Strategic & Transaction Advisory team’s strong commitment to helping clients navigate complex, multi-faceted processes with thoughtful, results-driven solutions,” added Brian Williams, Managing Partner of CMA.
The M&A Advisor Turnaround Awards recognize excellence in distressed transactions, restructurings, refinancings, and corporate turnarounds, honoring leading firms, professionals, and deals globally.
###
